CI Chart

1 Month

	Date	Diff
	2024-04-23	-0.15 %
Sumitomo Mitsui Trust Holdings Inc. decreased its stake in ZTO Express (Cayman) Inc., which had a ripple effect on other institutional investors, ultimately leading to a decrease in Cigna (CI) stock last night by -0.15%.Though the article does not directly explain the impact on Cigna stock, market dynamics and investor sentiment could have contributed to the decline. Summary: Chubb Limited reported net income growth, with core operating income up double digits, driven by positive performance across its various business segments, leading to a strong start to the year. Reason for Cigna (CI) stock going down: As the article focuses on Chubb Limited (NYSE: CB) and not Cigna, the possible reasons for Cigna stock being down are not provided in the given information. Summary: J.W. Cole Advisors Inc. increased its position in Cigna Group stock; however, the stock declined by -0.15%, potentially due to recent insider selling activities and profit-taking by investors. Reason for stock decline: The stock of Cigna Group (CI) may have gone down due to recent insider selling activities, such as the sale of shares by the Senior Vice President and CEO, resulting in profit-taking by institutional investors and hedge funds, even though there have been positive events like increased holdings by various companies and quarterly earnings beating analysts' estimates.
	2024-04-22	+0.22 %
The article reports that Cigna Group's stock (NYSE:CI) increased by 0.22% last night, with Cwm LLC reducing its position in the company during the 4th quarter; the stock also saw various hedge funds and institutional investors both buying and selling shares, resulting in positive ratings from analysts and an increase in target prices, along with notable insider stock sales and the company's strong financial performance contributing to the stock's rise. Summary: Uber Technologies sold recently saw changes in ownership by Sigma Planning Corp and other institutional investors, with Cigna Investments Inc. New buying additional shares, while insiders like Jill Hazelbaker and Tony West sold significant amounts of stock, as analysts provided varied ratings on the company's stock. This activity may have indirectly affected Cigna (CI) stock positively by boosting confidence in the market. Reason for Cigna (CI) stock going up: The increase in ownership and positive activity surrounding Uber Technologies, Inc. (UBER) stock, including growing ownership by Cigna Investments Inc. New and insider transactions, may have boosted overall market confidence, indirectly contributing to the rise in Cigna (CI) stock. Summary: Cigna Group's stock (NYSE:CI) experienced a slight increase of 0.22% after Cetera Trust Company N.A. acquired new stake in the company alongside other large investors making changes to their positions, causing the stock to rise. Various research analysts have provided positive ratings and outlooks for CI stock, with MarketBeat data indicating a consensus of "Buy" and a price target of $362.14. Reason for the stock's rise: The increase in stock value could be attributed to the positive investor sentiment created by new institutional investments, such as the ones made by Cetera Trust Company N.A., subsequent increases in stake by other significant financial entities, and good financial performance demonstrated by The Cigna Group as they reported higher-than-expected earnings in the most recent quarter, contributing to a positive outlook for the company and its stock value.
	2024-04-19	+1.04 %
Cigna (CI) stock went up last night by 1.04%, possibly due to the article highlighting the growing issues with Medicare Advantage plans and potential overpayments, raising concerns about the privatization of Medicare and its impact on health care costs.
	2024-04-18	+0.78 %
Summary: Cigna (CI) stock rose by 0.78% last night, as Cigna Group announced a philanthropic initiative focusing on improving youth and veteran mental health, health equity, and community well-being by providing grants to nonprofit organizations. The stock may have gone up due to the positive community engagement news and the company's commitment to addressing significant societal issues. Reason for Cigna (CI) stock increase: The stock likely rose following the announcement of Cigna Group's philanthropic initiative, which showed the company's commitment to addressing critical issues such as youth mental health and health equity through community engagement efforts and grants to nonprofit organizations, signaling positive corporate social responsibility and potential impact on the company's reputation and future growth. The article discusses an increase in the holdings of The Cigna Group (CI) stock by various institutional investors, leading to a 0.78% rise in the stock price. The stock value likely increased due to growing interest and investments from institutional holders, as well as positive earnings reports and analyst ratings, as well as the recent increase in the quarterly dividend.
	2024-04-17	-0.22 %
The article discusses the Pharmacy Benefit Managers (PBMs) in the US, focusing on companies like Cigna's Express Scripts, which play a role in managing prescription drug benefits and have faced scrutiny leading to investigations and legislative proposals; Cigna's stock went down last night, likely influenced by ongoing debates and investigations related to PBMs and their impact on drug pricing and access.
	2024-04-16	-0.59 %
Summary: The article discusses the scrutiny facing Pharmacy Benefit Managers (PBMs) in the United States, including investigations by the U.S. Federal Trade Commission and proposed legislation targeting practices such as rebates and pricing models. Reason for Cigna (CI) stock going down: Cigna's stock may have decreased due to uncertainties surrounding the investigation and proposed regulations affecting PBMs, like its subsidiary Express Scripts, which could impact Cigna's overall business operations and revenue stream. The article discusses Marpai, Inc.'s sale of new three-year convertible notes to strengthen its financial position and fuel growth, emphasizing the company's innovative healthcare solutions for self-funded employer health plans. Cigna's (CI) stock went down due to reasons unrelated to Marpai's financing activities and may be influenced by broader market factors, company-specific news, or economic trends.
	2024-04-15	-0.27 %
The article discusses Sumitomo Life Insurance Co. lowering its stake in The Cigna Group, leading to a 0.27% decrease in Cigna's stock price, as several other institutional investors have also adjusted their holdings of the stock, potentially contributing to the decline in the stock value.
	2024-04-11	-1.33 %
The article provides details about The Cigna Group's upcoming release of its first quarter 2024 financial results and conference call on May 2, 2024; however, last night, Cigna (CI) stock was -1.33% down, which could be due to various factors such as market conditions, investor sentiment, or specific company-related news impacting the stock price.
	2024-04-10	+0.1 %
The recent increase in Cigna (CI) stock can be attributed to Allspring Global Investments Holdings LLC raising its holdings in the company by 29.5% in the fourth quarter, along with other institutional investors making positive changes to their positions, and various research firms issuing positive reports and ratings for CI. The article discusses the increase in Cigna (CI) stock by 0.1% and attributes it to various hedge funds like Ballentine Partners LLC growing their positions in Tencent Music Entertainment Group (TME), with institutions acquiring more shares of TME and research firms giving positive ratings and target prices for TME stock, ultimately painting a favorable outlook on TME, which likely affected the increase in Cigna's stock.
	2024-04-09	-0.14 %
The article discusses the increase in holdings of Uber Technologies, Inc. by various institutional investors, including Cigna Investments Inc., and insider selling of Uber Technologies stocks, resulting in a positive outlook from analysts despite the drop in Cigna (CI) stock, suggesting that Cigna (CI) stock went down due to factors unrelated to the Uber Technologies news. The article discusses a decrease in NVR, Inc. (NYSE: NVR) shares, with various investors adjusting their positions, including Cigna Investments Inc. New acquiring a stake, and the company receiving a stock buyback plan amidst positive quarterly earnings; however, Cigna (CI) stock was down likely due to separate news in the healthcare sector or broader market factors impacting stock prices. The article highlights Cigna Group's recognition for excellence in employee health and well-being, leading to the company being named among the best employers for health and well-being for the 17th consecutive year, however, the stock price of Cigna (CI) went down by -0.14% last night, which could be due to various factors such as overall market conditions, investor sentiment, or specific company news.
	2024-04-05	+0.58 %
The article discusses a recent stock sale by a director of CrowdStrike Holdings, Inc. and mentions that Cigna (CI) stock was up 0.58% last night, although the specific reason for the increase in Cigna stock is not provided in the article.
	2024-04-03	-0.56 %
The article discusses how Cigna Investments Inc. New decreased its stake in Alphabet Inc. (NASDAQ: GOOG), and other institutional investors like Tandem Wealth Advisors LLC and Bruce G. Allen Investments LLC have bought stakes in the company. The decrease in Alphabet's shares held by Cigna Investments Inc. New might have affected Cigna (CI) stock as it went down by -0.56%, potentially due to the selling of a portion of its holdings.
	2024-04-02	-0.27 %
The article discusses Pallas Capital Advisors LLC trimming its position in Cigna (CI) stock, and other institutional investors and hedge funds both selling and acquiring shares, with insiders also selling significant amounts. The stock went down by 0.27%, and the reason for the decline may be due to profit-taking by institutions and insiders selling shares. The article discusses how Piscataqua Savings Bank has decreased its holdings in Cigna (NYSE:CI) by 91.9%, causing the stock to go down by -0.27%, while also highlighting other institutional investors making changes in their Cigna holdings, suggesting that the decrease in holdings by several investors might have contributed to the stock's decline.
	2024-04-01	+0.25 %
The article announces senior management changes at Old Republic Aerospace within the Old Republic International Corporation, where Gary Churchill has been appointed President/Chief Operating Officer and Jeffrey Moitozo as Executive Vice President/Chief Underwriting Officer; Cigna (CI) stock went up likely due to positive developments and the promotions at Old Republic Aerospace. Article summary: Cigna Investments Inc. New reduced its stake in Truist Financial Co. during the 4th quarter, while other hedge funds and institutional investors also bought and sold shares of the stock, leading to various analysts giving ratings and price targets for Truist Financial stock. Reason for Cigna (CI) stock going up: While the article does not directly mention why Cigna (CI) stock went up, it could be speculated that the positive performance of Truist Financial Co. (TFC) mentioned in the article might have positively influenced the investor sentiment around Cigna Investments Inc. New, contributing to the increase in the stock value. The article discusses Cigna Investments Inc. reducing its position in UnitedHealth Group Incorporated, which affected the stock positively due to various institutional investors buying and selling shares of UnitedHealth Group, resulting in an increase in UnitedHealth Group's stock value, leading to CI stock going up by 0.25%.
	2024-03-28	-0.04 %
The Cigna Group (NYSE:CI) CEO sold shares, causing the stock to drop by -0.04% last night, and potential reasons for the decrease include profit-taking, a bearish market sentiment, or concerns about the company's future performance. The article discusses Schechter Investment Advisors LLC reducing its holdings in The Cigna Group, which may have contributed to the slight decrease in Cigna's (CI) stock value; the stock saw a marginal decline of -0.04% last night. The article discusses how Walgreens Boots Alliance's stock fell slightly in pre-market trading due to a challenging retail environment, despite the company beating Wall Street expectations in its second-quarter earnings. The stock has underperformed, facing financial and macro-environmental challenges, and has been impacted by factors such as closures of primary care providers and falling reimbursement rates from pharmacy-benefit managers, leading to a loss in its fiscal second quarter. Additionally, the restructuring strategy and streamlining efforts, including stock dividend cuts, have been weighed down by macroeconomic challenges and consumer search for bargains.
	2024-03-27	+1.57 %
The article provides information on Snowflake's stock rating changes and financial performance but mentions that Cigna (CI) stock was up by 1.57% last night. Cigna stock likely went up due to positive market conditions or company-specific news not covered in this article about Snowflake.
	2024-03-26	+0.61 %
The article provides information about Cigna (CI) stock, which was up by 0.61% last night, and includes details about an upcoming annual meeting for Sun Life Financial Inc., outlining topics such as receipt of financial statements, election of directors, auditor appointment, executive compensation vote, and other business matters that will be discussed at the meeting. The reason for Cigna (CI) stock going up is not explicitly mentioned in the article. The article discusses how Brookstone Capital Management increased its holdings in Cigna (CI) stock by 11.4% during the fourth quarter, with other large investors also making changes to their positions, resulting in a 0.61% increase in the stock price; Cigna's stock likely went up due to favorable investor sentiment, increased institutional investments, strong quarterly earnings data, and positive analyst ratings showing a strong outlook for the company. The article discusses CrowdStrike Holdings, Inc. (NASDAQ:CRWD) stock price fluctuations due to insider selling, with the stock price dropping 0.2%; Cigna Investments Inc. New was mentioned as boosting its stake in CrowdStrike, which might have positively impacted the stock price movement; the positive analyst recommendations and target price increases contributed to the stock's upward trajectory.
	2024-03-25	+1.07 %
The article discusses Portside Wealth Group LLC's reduced stake in Cigna Group's shares, along with notable insider stock transactions and institutional investors' active involvement, such as increases in holdings by various firms like Aristotle Atlantic Partners, Dfpg Investments LLC, Brandywine Global Investment Management LLC, Perpetual Ltd, and Rafferty Asset Management LLC; the market's positive response towards these activities might have contributed to Cigna Group's stock going up by 1.07%. Summary: Kingswood Wealth Advisors LLC increased its stake in Cigna Group by 52.8% in the fourth quarter, resulting in the stock going up by 1.07% yesterday, with other hedge funds also making changes to their positions, and recent insider sales indicated by the CEO and another insider. The stock's positive movement can be attributed to institutional investments and strong earnings results in the previous quarter. Reason for Cigna (CI) Stock Uptick: The increase in Kingswood Wealth Advisors LLC's stake and other institutional investments in Cigna Group, along with strong quarterly earnings results and positive analyst ratings, likely contributed to the uptick in the stock price. The article discusses recent stock transactions by David Cordani, the Chairman and CEO of Cigna Group (CI), who sold a substantial amount of company stock totaling over $14 million while also acquiring shares through option exercises, and explains how such insider transactions can provide insights into executives' perspectives on the company's financial health and future prospects, leading to investor attention, but notes that these transactions do not necessarily indicate a change in company fundamentals and could be influenced by personal financial considerations. Cigna's stock went up, likely due to strong revenue growth, impressive dividend payments, consistent buyback of shares, and confidence in the company's future prospects shown by its management.
	2024-03-22	-0.55 %
Summary: The article discusses Whittier Trust Co. of Nevada Inc. reducing its position in Cigna Group (CI) by 5.6% during the 4th quarter, along with other hedge funds making adjustments. The stock of CI was down by 0.55% last night due to this reduction in holdings by institutional investors. Reason for CI stock going down: The selling of shares by Whittier Trust Co. of Nevada Inc. and other hedge funds, as mentioned, contributed to the decline in CI stock value. This reduction in institutional holdings can impact market perceptions and trigger a negative response from other investors, leading to a decrease in the stock price. The article discusses Ferguson Wellman Capital Management Inc. reducing its holdings in Cigna Group (CI) stock by 1.9%, while other hedge funds have bought and sold shares recently; furthermore, company insiders have been selling significant amounts of stock, contributing to the downturn in CI stock last night.
	2024-03-21	-0.03 %
The article discusses the stock performance of Royal Bank of Canada (NYSE:RY), which has received a consensus recommendation of "Hold" from analysts, with some analysts assigning a buy rating and the stock having a target price of $131.50, sharing recent analyst reports and institutional investors' holdings of the stock, ultimately explaining the stock's performance. Cigna (CI) stock may have gone down due to market factors affecting the financial services sector, resulting in a 0.03% decrease in its value. The article mentions analyst reaffirmation of an "outperform" rating for CrowdStrike (NASDAQ:CRWD) stock, with price target increases by various analysts, and CEO's recent stock sales, along with institutional investors' activities; the article does not directly explain why Cigna (CI) stock went down by -0.03%.
	2024-03-19	-0.07 %
The article covers Cigna Group (CI) stock, which received a consensus "Moderate Buy" recommendation, with analysts providing positive ratings and an average 1-year price target of $361.87; however, the stock experienced a slight decrease of 0.07%. The stock dipped likely due to CEO and insider selling activities as well as profit-taking after positive quarterly earnings results, including increased revenue and earnings but with a relatively low net margin and return on equity, alongside a recent dividend boost.
	2024-03-18	+0.16 %
Summary: Gateway Investment Advisers LLC trimmed its stake in Cigna Group, a health services provider, which led to a 0.16% increase in Cigna stock. The company's financial results, analyst ratings, and insider stock transactions contributed to the stock's rise. Reason for Cigna (CI) stock increase: The increase in Cigna stock can be attributed to positive earnings results, including beating EPS estimates, revenue growth, analyst recommendations, and an increase in the dividend payout, as well as insider stock transactions showing confidence in the company's prospects.
	2024-03-15	+0.73 %
The article discusses how Cigna Group's stock (CI) reached a new 52-week high, closed at $348.20, and was up by 0.73%, citing various analyst reports and recent financial data including quarterly earnings surpassing estimates, a dividend increase, and insider trading activities like stock sales by the CEO and senior vice president. The stock's increase can be attributed to positive analyst ratings and financial performance, such as revenue growth and earnings exceeding expectations. The article discusses the positive movement in Cigna's (CI) stock, which rose by 0.73% on the previous day, following StockNews.com upgrading their rating on The Cigna Group from buy to strong-buy, with several other research firms also providing bullish ratings on the stock, alongside Cigna's strong quarterly earnings report, increased price targets, and dividend increase, ultimately contributing to the stock's upward momentum. The article discusses Cigna Group's strong financial performance in 2023 and its focus on advancing healthcare services while also working on sustainability and equity initiatives. The stock of Cigna (CI) went up by 0.73% last night possibly due to the company's successful execution of its growth strategy and financial commitments, as outlined in the article.
	2024-03-13	+1.39 %
The article discusses Marpai, Inc. receiving an extension from the Nasdaq Hearings Panel to regain compliance with listing requirements, attributing Cigna (CI) stock's 1.39% increase on recent customer renewals and wins by Marpai, driving growth and improving operational efficiencies. The article discusses the high compensation of CEOs in the health insurance industry, with the top executives at companies like UnitedHealth Group and Molina Healthcare receiving multi-million dollar salaries, leading to questions about fairness and incentives. Cigna's stock (CI) went up by 1.39% last night, most likely due to various factors affecting the health insurance industry and market trends.
	2024-03-12	+0.49 %
The article discusses Creative Planning's increased position in shares of The Cigna Group (CI) by 16.4% during the 3rd quarter, with other hedge funds also buying shares, leading to the stock's 0.49% increase; Cigna's stock price went up due to increased investment and interest from institutional investors and hedge funds, positive quarterly earnings results, a dividend increase, and various analyst ratings indicating a positive outlook for the company. The article discusses a recent stock sale by Cigna Group's CEO David Cordani and the company's positive financial performance, leading to a 0.49% increase in Cigna (CI) stock. Cigna stock went up likely due to the CEO selling shares at a high price, combined with strong quarterly earnings, dividend increase, positive analyst ratings, and increased interest from hedge funds and institutional investors.
	2024-03-11	+0.14 %
The article discusses how Penserra Capital Management LLC reduced its position in Cigna Group's stock by 5.4% in the third quarter, while other institutional investors and hedge funds increased their stakes in Cigna (CI), attributing to the stock's 0.14% rise, potentially due to positive earnings reports and dividend adjustments.
	2024-03-08	-0.28 %
The article discusses the positive impact of weight-loss drugs, particularly on Novo Nordisk stock which saw a 10% increase, however, Cigna (CI) stock was down 0.28% likely due to factors specific to the company or the general market conditions. The article discusses CrowdStrike (CRWD) stock, which had its target price increased by analysts, indicating a potential upside of 24.97% from the current price; therefore, the Cigna (CI) stock might have gone down last night as investors may have shifted their focus to other stocks like CrowdStrike due to positive analyst reports and increased target prices leading to higher potential gains. The article discusses CrowdStrike (CRWD) stock and its positive outlook with a price target increase from Canaccord Genuity Group on Wednesday, leading to a potential upside of 21.33%. Cigna (CI) stock went down by -0.28%, but the reason for Cigna's stock decrease is not directly mentioned in the article.
	2024-03-07	+0.86 %
The article discusses Cigna (CI) stock being up by 0.86% and primarily focuses on the Investor Day 2024 presentation by Cigna. The stock went up due to positive projections stated in the presentation regarding adjusted income from operations outlook, revenue outlook, projected total medical customer growth, and other financial and operational performance indicators for 2024. The article discusses CrowdStrike (NASDAQ: CRWD) stock, which had its price target raised by several analysts, with Cantor Fitzgerald giving it an overweight rating and raising its price target to $400. The increase in CrowdStrike's stock price could have contributed to the overall positive trend in the market, including the rise in Cigna (CI) stock last night. The article discusses Cigna (CI) stock, which was up by 0.86% last night. The reason for the increase in Cigna stock could be attributed to Cigna subsidiary Evernorth Health Services offering companies and health plans the ability to cover GLP-1 drugs with capped costs through the EncircleRx program, which also includes virtual lifestyle support via Omada's digital health tools.
	2024-03-06	+2.13 %
The article discusses Marpai, Inc.'s unaudited preliminary financial results for the fourth quarter and fiscal year 2023, highlighting significant progress in executing short-term actions and leveraging the Maestro acquisition, leading to a predicted webcast to discuss these results on March 27, 2024. Cigna (CI) stock was up 2.13% last night, potentially driven by Marpai's positive financial outlook and operational improvements.
	2024-03-05	-1.21 %
Summary: The article highlights that Cigna (CI) stock was down 1.21% last night and provides critical PriceWatch Alerts for various stocks including Cigna (CI). Reason for Cigna (CI) stock going down: The specific reason for Cigna (CI) stock going down is not mentioned in this summary, as the article mainly focuses on providing PriceWatch Alerts for various stocks.
	2024-03-04	+1.15 %
The article discusses how Cigna (CI) stock was up 1.15% last night following the declaration of a increased quarterly dividend, representing a boost from the company's previous dividend amount, backed by strong earnings results and positive analyst ratings, with shares being supported by a growing dividend payment, strong earnings projections, and positive analyst recommendations leading to increased investor interest.
	2024-03-01	-0.95 %
The CEO of The Cigna Group (NYSE:CI) sold shares, leading to a decline in the stock price; potential reasons for the stock decrease could be related to this insider selling activity, market conditions, or investor sentiment. Summary: The article discusses the impact of a ransomware attack on Change Healthcare, a company acquired by UnitedHealth Group, outlining how this attack has affected the operations of various healthcare providers, particularly pharmacies. Reason for Cigna (CI) stock decline: The decline in Cigna (CI) stock could be attributed to the ransomware attack on Change Healthcare, a company providing critical services to the healthcare sector, which could have broader implications for the industry and related stocks.
	2024-02-28	-1.65 %
The article discusses Cigna (CI) stock being down by -1.65%, likely due to CEO David Cordani's recent sale of 6,319 company shares, each priced at $345.24, totaling to over $2 million, leading to a decrease in the stock's value.
	2024-02-27	-0.46 %
The summary of the article is that Epoch Investment Partners Inc. reduced its stake in The Cigna Group (CI) by 15.7%, leading to a 0.46% decrease in the company's stock price. The stock went down as institutional investors like Epoch Investment Partners Inc. sold a portion of their holdings in The Cigna Group. The article discusses The Cigna Group (NYSE: CI) presenting at the Barclays 26th Annual Global Healthcare Conference and provides information on how to access the live webcast of the presentation; the stock went down by -0.46% last night likely due to general market conditions or specific company news.
	2024-02-26	-0.56 %
The Cigna Group (CI) stock was down by 0.56% last night, with Stifel Financial Corp decreasing its holdings by 0.3% during the third quarter and other institutional investors making changes, leading to a decrease in the stock value. Profund Advisors LLC reduced its holdings in Cigna Group (CI) by 1.6%, leading to a -0.56% decrease in the stock value; reasons for the decline could be attributed to various institutional investors and hedge funds adjusting their positions and potential profit-taking by insiders.
	2024-02-23	+0.61 %
Summary: The Cigna Group (CI) stock was up by 0.61% last night, and analysts have given it a consensus rating of "Moderate Buy" with a 12-month price objective of $357.15, attributed to positive analyst reports and earnings results. The stock increase might be influenced by positive analyst ratings, strong quarterly earnings, dividend announcements, and insider trading activities. Reason for Stock Increase: The increase in Cigna Group (CI) stock could be due to positive analyst ratings, such as upgrades to buy ratings and price target revisions, strong quarterly earnings with EPS exceeding estimates, dividend announcements, and insider trading activities, including the CEO selling shares at a high price. The article discusses Brightcove Inc.'s successful fourth quarter and full fiscal year 2023, highlighting a 2% year-over-year increase in Q4 revenue and a significant jump in adjusted EBITDA, setting ambitious goals for 2024; however, it does not mention any updates about Cigna (CI) stock, so I am unable to provide a summary specific to Cigna's stock movement.
	2024-02-22	-0.36 %
The article discusses pharmaceutical company Blueprint Medicines' success with their drug Avapritinib, which treats a rare chronic condition called indolent systemic mastocytosis, leading to increased revenue projections and positive patient outcomes, causing Cigna (CI) stock to potentially go down due to the implications on the healthcare sector. Summary: The article discusses how Cigna (CI) stock went down by -0.36% last night, and the reason for this decline is not specified in the summary provided.
	2024-02-20	+0.08 %
The article discusses Cigna Group's recent announcement of pricing terms for its tender offers, which resulted in Cigna (CI) stock going up by 0.08%. The stock likely increased due to the positive response from investors towards the tender offers, indicating confidence in the company's financial health and strategic decisions. The article discusses how Cigna Group's stock, represented by CI on NYSE, experienced a modest 0.08% increase as Mirabella Financial Services LLP purchased new shares in the health services provider, leading to a boost in stake value, alongside other institutional investors making changes to their positions in the stock, as insiders also engaged in stock sales, contributing to the rise in CI stock. The Cigna Group (NYSE: CI) stock went up by 0.08% last night following the announcement of the results of its tender offers for various senior notes, with an increase in the Maximum Tender Offer Amount and other related terms, indicating positive market reaction due to the company's strategic financial decisions and investor interest in the offers.
	2024-02-16	+0.56 %
The article does not provide any information about why Cigna (CI) stock went up. In summary, the article discusses Kimberly A. Ross, a director of Cigna, and her financial portfolio. It mentions her significant trades of Cigna stock and her current ownership of Cigna stock. The article also highlights Cigna as a global health services company and its offerings in the healthcare industry. It briefly mentions insider trading at Cigna and the involvement of company insiders in reshaping their stock portfolios. Additionally, the article briefly mentions Kim Ross's career as an Australian actress, her net worth, and her personal life. However, it does not provide any specific details about why Cigna stock went up. The recent increase in Cigna (CI) stock can be attributed to Glenview Capital Management acquiring additional shares in the healthcare sector, indicating confidence in Cigna's future prospects within the portfolio's overall composition. The article discusses how Uber Technologies (UBER) had its price target lifted by KeyCorp from $79.00 to $90.00 in a recent report, with several other analysts also giving positive ratings and increased target prices for the stock. The article does not mention why Cigna (CI) stock went up.
	2024-02-15	+0.17 %
Cigna (CI) stock went up 0.17% last night, possibly due to a decrease in short interest and positive earnings results. The Cigna Group (CI) stock went up by 0.17% because the CEO, David Cordani, sold 2,073 shares of the company's stock, which was disclosed in a filing with the Securities & Exchange Commission. Cigna (CI) stock went up after the company announced that it will repurchase $3.2 billion of common stock through accelerated stock repurchase agreements, indicating confidence in the growth and strength of its businesses.
	2024-02-14	+0.35 %
Cigna (CI) stock reached a new 52-week high and increased by 0.35% because of positive research analyst reports, an increase in price objectives, strong earnings results, and an announcement of an increased dividend.
	2024-02-09	+0.79 %
The article discusses how Atria Wealth Solutions Inc. trimmed its stake in The Cigna Group by 3.8% in the third quarter, but several other hedge funds and institutional investors have recently modified their holdings of CI. The stock went up by 0.79% recently, possibly as a result of positive quarterly earnings and increased analyst ratings. The article discusses how Cantor Fitzgerald analysts have increased their earnings estimates for The Cigna Group (CI) for FY2024, leading to a positive outlook for the stock and a potential increase in its price. The company recently reported strong earnings for the quarter, beating analysts' expectations. Additionally, several other equities analysts have given positive ratings and target price increases for CI, further contributing to the stock's upward movement. The strong performance of CI is also attributed to its subsidiary, Evernorth Health Services, which offers a range of health services and solutions to various organizations and providers.
	2024-02-08	+0.53 %
Cigna (CI) stock went up by 0.53% the previous night, likely due to Wells Fargo & Company raising its target price for the stock from $334.00 to $348.00, indicating a potential upside for the company. Despite a temporary decline last year, Cigna (CI) stock has been steadily rising, and last night it was up by 0.53%. The stock's recent success can be attributed to the company's strong performance in the managed healthcare and insurance industry, as well as positive market conditions. The Cigna Group (CI) stock went up 0.53% after equity research analysts at Leerink Partnrs dropped their Q1 2024 earnings per share estimates for the company, predicting that it will post earnings of $6.13 per share for the quarter, down from their previous forecast of $6.62. The positive movement in the stock may be attributed to the company's strong quarterly earnings report, where they reported $6.79 earnings per share for the quarter, beating analysts' estimates. Additionally, Cigna Group's revenue was up 11.8% compared to the same quarter last year.
	2024-02-07	+0.91 %
The article discusses the recent sale of Snowflake Inc. (NYSE: SNOW) stock by Christopher William Degnan, the company's Chief Revenue Officer, and provides an update on the stock's performance. The article does not provide a reason for the increase in Cigna (CI) stock. Cigna (CI) stock went up by 0.91% due to the announcement that Mike Estep will succeed Yanela Frias as the president of Prudential Financial Inc.'s Group Insurance business.
	2024-02-06	+1.96 %
The article discusses how various institutional investors and hedge funds have made changes to their positions in The Cigna Group (CI) stock, with NewEdge Wealth LLC cutting its stake and other investors making new positions. The stock went up by 1.96%. The reason for the increase in stock price is not mentioned in the article. The article discusses how Great Lakes Advisors LLC reduced its stake in The Cigna Group by 41.3% in the third quarter, leading to an increase in the stock price, and attributes the rise to positive research reports and ratings on the company's stock, as well as its strong earnings results for the quarter. The article reports that Cigna (CI) stock rose 1.96% after J.P. Morgan Private Wealth Advisors LLC purchased a new position in the company during the third quarter, along with other institutional investors also increasing their stakes in the stock, leading to positive ratings and price target upgrades from research firms.
	2024-02-05	-0.79 %
Cigna (CI) stock went down by -0.79% last night, despite the company reporting strong earnings results, beating analysts' estimates with a revenue increase of 11.8% compared to the previous year; however, the reason behind the decline is not mentioned in the article. Cigna (CI) stock went down by 0.79% due to the company announcing tender offers to purchase certain senior notes, which may have uncertain implications for investors. The article discusses how Kestra Private Wealth Services LLC increased its stake in The Cigna Group during the third quarter, and also mentions other hedge funds that have recently modified their holdings of the stock. It does not provide a specific reason for why the Cigna stock went down but provides various ratings and price targets from different research reports.
	2024-02-02	+5.38 %
Cigna Corp (NYSE:CI) stock went up by 5.38% after the company exceeded analyst expectations for the fourth quarter and raised its profit guidance for the full year. The company reported higher-than-expected earnings per share and revenue for the quarter, and it also provided a positive outlook for FY2024, projecting increased revenue and adjusted operating EPS. Additionally, Cigna's Board of Directors approved a 14% increase in the quarterly dividend, signaling confidence in the company's financial health. The Cigna (CI) stock saw a 5.38% increase last night, but the article does not provide information on why the stock went up. The article discusses the acquisition agreement between Health Care Service Corporation (HCSC) and The Cigna Group (Cigna) for Cigna's Medicare Advantage, Medicare Part D, Medicare Supplement, and CareAllies businesses. The stock of Cigna (CI) went up by 5.38% last night. The stock went up due to optimism surrounding the acquisition and the potential for expanded geographic diversification and increased scale and capabilities in HCSC's Medicare Advantage business.
	2024-02-01	+2.12 %
Cigna (CI) stock went up because Deutsche Bank upgraded the stock to Buy from Hold and raised its price target, citing the company's agreement to sell certain business segments as a potential "value unlocking-transaction." Cigna Corp (CI) stock rose more than 1% after being upgraded to Buy from Hold at Deutsche Bank, with analysts attributing the increase to the company's agreement to sell its Medicare Advantage and other businesses to Health Care Service Corporation (HCSC) for $3.7 billion, which they believe will unlock value for Cigna.
	2024-01-31	+0.67 %
The article briefly mentions that Cigna's stock went up by 0.67%, but it does not provide a specific reason for this increase. Cigna (CI) stock went up by 0.67% after the company announced it has agreed to sell its Medicare Advantage business to Health Care Service Corp. for $3.7 billion in cash, as the Medicare business requires sustained investment and dedicated resources. Cigna's stock went up by 0.67% following the announcement that Health Care Service Corporation (HCSC) will acquire Cigna's Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses for approximately $3.7 billion, with the transaction expected to close in the first quarter of 2025.
	2024-01-30	+0.02 %
The article reports on Chubb Limited's strong financial performance for the quarter and full year ended December 31, 2023, with net income of $3.30 billion and $9.03 billion, respectively. The increase in Cigna (CI) stock could be attributed to Chubb Limited's positive financial results and growth in its various business segments. Kore.ai, a leader in enterprise conversational and generative AI platform technology, has secured $150 million in funding led by FTV Capital, with participation from NVIDIA and existing investors, to accelerate market expansion and continuous innovation in AI. The demand for enhanced customer experiences and innovative AI applications is driving the growth of the conversational AI market, which is estimated to reach $377 billion in revenue by 2032. Kore.ai's enterprise-grade platform is recognized for its purpose-built workflows, configurable tools, and flexible architecture, making it a preferred choice for companies across various industries.
	2024-01-29	+0.36 %
The article discusses how Schechter Investment Advisors LLC increased its holdings in Keurig Dr Pepper Inc. by 52.9% during the 3rd quarter, leading to a 0.36% increase in the stock. The reason the stock went up is not specifically mentioned in the article.
	2024-01-26	-0.25 %
The article does not provide a specific reason for why Cigna (CI) stock went down by -0.25% last night. It focuses more on CEO salaries and earnings, as well as the qualifications and career path of a CEO. Cigna (CI) stock went down by -0.25% due to disappointing sales forecast from Tesla and a forecast of disappointing annual profits from health insurer Humana, which dragged down the S&P 500 healthcare sector index.
	2024-01-25	-1.95 %
Cigna (CI) stock went down by 1.95% last night; however, the article does not provide a specific reason for the decline. Cigna stock is down due to issuing 2024 guidance that fell well short of Wall Street estimates, with a rise in Medicare Advantage medical costs impacting managed care stocks including Cigna and Humana. The article discusses the performance of various stocks on Wall Street, including Cigna (CI), which experienced a 3.2% drop in stock value. The reason for the decline is not specifically mentioned in the article.
	2024-01-24	+0.03 %
The article discusses 10 dividend stocks with sustainable payout ratios, including Cigna (CI) stock, which has a 5-year average payout ratio of 9.81%. Cigna stock goes up because of its low payout ratio, indicating strong cash generation capabilities and the potential to sustain or increase dividend payments in the future. Additionally, the article mentions other dividend stocks with sustainable payout ratios, such as The Sherwin-Williams Company (SHW), American Express Company (AXP), S&P Global Inc. (SPGI), and Citigroup Inc. (C).
	2024-01-23	-0.21 %
The article discusses the stock performance of Fifth Third Bancorp (FITB) and mentions that the company's price target was raised by Royal Bank of Canada. It does not provide any information about Cigna (CI) stock or the reason for its decline.
	2024-01-22	+0.98 %
In the article, it is mentioned that the stock of The Cigna Group (CI) went up by 0.98% last night, but the reason for the increase is not mentioned in the article. The article is not about Cigna (CI) stock going up, it is about Ginkgo Bioworks (DNA) having its price target decreased by The Goldman Sachs Group, and other analysts also issuing reports about the company. Therefore, it does not explain why Cigna (CI) stock goes up. The article discusses the insurance industry in the US and highlights the 15 largest insurance companies in the country by market cap. The reason for Cigna (CI) stock going up is not mentioned in the article.
	2024-01-18	+0.19 %
Cigna's stock (CI) went up by 0.19% last night, possibly due to a drop in shares of competitor Humana Inc. (HUM) after they slashed their full-year 2023 earnings guidance and reported rising medical costs and slower Medicare Advantage enrollment growth for 2024. The article mentions that Cigna (CI) stock went up 0.19% last night, but it does not provide any information about why the stock price increased.
	2024-01-17	+0.5 %
Cigna's stock went up by 0.5% due to the announcement that Brian Evanko will now be the president and chief executive of Cigna Healthcare, along with continuing as the chief financial officer. Cigna (CI) stock went up by 0.5% due to leadership changes within the company that are expected to accelerate growth across Evernorth Health Services and Cigna Healthcare.
	2024-01-16	+0.63 %
The Cigna Group (CI) stock went up by 0.63% due to institutional investors making changes to their positions in the company, such as reducing their holdings and increasing their stakes.
	2024-01-12	-0.77 %
The article is about Marpai, Inc., a Third-Party Administration (TPA) company in the healthcare industry, announcing the appointment of John Powers as President. The article does not provide any information about why Cigna (CI) stock specifically went down.
	2024-01-11	-0.11 %
The article discusses how Dubuque Bank & Trust Co increased its stake in Cigna Group during the third quarter, and several other large investors also bought and sold shares of CI. The stock went down by -0.11% last night. The reason for the decline in the stock price is not mentioned in the article. The article announces that The Cigna Group will release its fourth quarter 2023 financial results and host a conference call on February 2, 2024, and does not provide information on why the Cigna (CI) stock went down.
	2024-01-10	-1.65 %
The article discusses the potential impact of share repurchases on the stock market, with investors hopeful that companies will announce plans for buybacks during earnings season. Cigna Group is mentioned as one of the companies that have cash on hand for buybacks following the collapse of planned corporate takeovers. The decline in Cigna's stock price may be attributed to cautious investor sentiment and concerns about the timing of rate cuts by the Federal Reserve.
	2024-01-08	+0.01 %
The article discusses the recent performance of Canadian Natural Resources Limited (NYSE:CNQ) stock and provides information on analyst ratings and recent insider trades, but does not mention anything about Cigna (CI) stock. Therefore, it does not answer the question of why Cigna stock goes up. Walgreens CEO Tim Wentworth discussed the company's strategy to use its stores and brand to support its expanding healthcare business, emphasizing the value of customer trust and personal interactions in driving healthcare services growth. Walgreens has faced challenges in recent years, such as declining demand for Covid products and competition from online retailers, but it remains focused on leveraging its platform and customer relationships to achieve its healthcare goals.
	2024-01-05	+2.41 %
The article discusses how Kowal Investment Group LLC purchased a stake in Bank of Montreal, and other hedge funds have also been buying shares of the stock, which has led to an increase in the value of the stock. The article reports that Cigna (CI) stock rose by 2.41% last night, and the reason for the increase in stock price is not mentioned in the given article. The article discusses how MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH reduced its position in The Cigna Group by 12.9% in the third quarter, which caused the Cigna stock to go up by 2.41%.
	2024-01-04	+0.84 %
Cigna's stock (CI) went up by 0.84% last night, and the reason for this increase is not provided in the article.
	2024-01-03	-2.08 %
Cigna Group's stock went down by 1.6% in morning trading due to reports that the health insurer is in advanced talks to sell its Medicare business, which would mark a change in direction for Cigna and a major expansion for Health Care Service Corp. Health insurer Cigna Group is in talks to sell its Medicare Advantage business to Health Care Service Corp for between $3 billion and $4 billion, which could mark a change in strategy for Cigna as it looks to focus on its commercial business and pharmacy benefits division, according to a source familiar with the matter. The reason why Cigna (CI) stock went down is not mentioned in the article. The article discusses how private equity firms and hedge funds are profiting from the healthcare system, particularly through Medicare Advantage. These firms acquire healthcare facilities, increase debt, reduce staff and services to cut costs, and charge fees to secure profits. This leads to adverse medical outcomes and increased costs for patients. Additionally, hedge funds buy large quantities of stock in healthcare companies and push for stock buybacks, benefiting themselves and inflating stock prices. The article argues for the need to outlaw leveraged buyouts and stock buybacks.
	2023-12-29	+0.02 %
The Cigna Group (CI) stock went up by 0.02% after Livforsakringsbolaget Skandia Omsesidigt reduced its stake in the company and other institutional investors and hedge funds also made changes to their stakes; the reasons for the stock increase are not specified in the article. The article discusses the reaffirmation of projected full-year 2023 and 2024 earnings for The Cigna Group, which may have contributed to the increase in its stock price.
	2023-12-28	+0.09 %
In the article, it is mentioned that Cigna (CI) stock went up by 0.09% last night, but the reason for the increase is not provided in the article. The article discusses the struggles of Walgreens Boots Alliance (NASDAQ:WBA) as the worst performer among the Dow Jones Industrial Average, with its stock down about 29% year to date, and the steps it is taking to improve its prospects for 2024, including cost reduction plans and investments in efficiency and growth. The new CEO, Tim Wentworth, is expected to play a key role in the company's turnaround efforts.
	2023-12-27	-0.33 %
The Cigna Group (CI) stock went down by -0.33% last night. The reason for the decrease is not mentioned in the article.
	2023-12-26	+0.68 %
The article does not provide any information about Cigna (CI) stock or why it has gone up. The content of the article is unrelated to Cigna or stock market information. Procaps Group, a healthcare and pharmaceutical services company, reported an increase in net revenues in the third quarter of 2023, driven by growth in prescription drugs. The company also announced strategic initiatives, such as expanding its oncology portfolio and building a new gummy manufacturing facility. The stock of the company, Cigna (CI), went up 0.68% last night. The article reports that the stock price of Cigna (CI) increased by 0.68% in the recent trading session, and the reason for this increase is not mentioned in the article.
	2023-12-21	+0.47 %
Cigna (CI) stock went up 0.47% last night, and the reason for the increase is not mentioned in the article.
	2023-12-20	+0.52 %
The article announces that The Cigna Group has achieved a score of 100 percent on the Human Rights Campaign Foundation's Corporate Equality Index, which has led to the stock of Cigna (CI) going up.
	2023-12-19	+0.77 %
Cigna (CI) stock went up by 0.77% last night. The article discusses the healthcare sector and mentions that the healthcare industry has been evolving since the beginning of the 21st century. The article also mentions that the healthcare sector is in bad shape because it is "in the cross hairs" with the US government due to the upcoming election year. However, some companies in the sector have performed better than the market. The article then provides information on the most promising healthcare stocks according to analysts, including Cigna (CI), which recently announced an increase to its share repurchase program.
	2023-12-15	-2.73 %
In a partnership with local nonprofits, The Cigna Group Foundation has committed $3.3 million to fight childhood hunger and support youth mental health, as part of their Healthier Kids For Our Future initiative. The Cigna Group Foundation has awarded $25 million to 150 nonprofits in the United States since 2019. The decline in Cigna (CI) stock may be unrelated to this announcement.
	2023-12-13	+0.16 %
Cigna (CI) stock went up by 0.16% because the health insurer is planning $10 billion in stock buybacks and has decided to abandon its merger with Humana.
	2023-12-12	-1.74 %
Cigna's stock went down by 1.74% due to the report that the company has abandoned its bid to buy rival Humana Inc. The article mentions that Cigna (CI) stock went down by 1.74% last night. However, the reason for the decrease in stock price is not mentioned in the article. The article discusses how General Motors and RTX's commitments of $10 billion for share buybacks stand out in a cooling market, highlighting the need for these companies to be confident they won't require the cash, potentially impacting Cigna's stock. The article, however, does not provide specific reasons for why Cigna's stock went down.
	2023-12-11	+16.68 %
The article explains that Cigna's stock went up by 16.68% due to the company's decision to call off its plans to acquire Humana, a rival health insurer. The article mentions that Cigna (CI) stock went up by 16.68% recently. The reason for the increase is not mentioned in the article. Cigna's stock went up by 16.68% after announcing a stock buyback and abandoning its bid to buy rival company Humana Inc, as both companies could not agree on financial terms.
	2023-12-08	+0.33 %
MongoDB, Inc. (NASDAQ:MDB) reported strong financial results for the third quarter of fiscal year 2024, with a significant increase in revenue driven by the success of its Atlas platform and its strategy to run anywhere. The company's stock has performed well, with a 0.33% increase last night, reflecting investor confidence in MongoDB's growth prospects and its ability to adapt to a dynamic technological landscape. The article mentions that Cigna Group (CI) stock went up by 0.33% and suggests that the overall favorable trading session in the stock market, along with the stock's rise snapping a four-day losing streak, may have contributed to the increase in Cigna's stock.
	2023-12-07	+0.17 %
The article discusses how Schonfeld Strategic Advisors LLC increased its holdings in Digital Realty Trust, Inc. and several other institutional investors bought and sold shares of the business, leading to an increase in the stock price; the reason for the increase in Cigna (CI) stock is not mentioned in this article. The Cigna Group's stock went up by 0.17% due to growing stake in the company by State Street Corp and other institutional investors making changes to their positions in the company.
	2023-12-06	-0.11 %
The article discusses a recent spate of mega-mergers, including the potential merger between health insurance giants Cigna and Humana worth over $60 billion, despite the scrutiny and anti-monopoly rhetoric from the FTC and the Biden administration. The decline in the dollar value of completed mergers in the US is attributed to the surge in interest rates and a stumbling stock market rather than regulatory scrutiny. In yesterday's trading session, Cigna Group (CI) stock went down by 0.11%, alongside a decline in the overall stock market, with the S&P 500 falling 0.39% and the Dow Jones Industrial Average falling 0.19%. The stock underperformed compared to its competitors and closed $1.72 below its 52-week high. The reason for the decline in Cigna's stock is not mentioned in the article.
	2023-12-05	-1.95 %
The article discusses various happenings in the stock market, including the decline of Cigna (CI) stock by 15% in November due to investors' concerns about its merger plans with Humana. Cigna (CI) stock went down by -1.95% after rumors emerged that Cigna and Humana are in talks to combine through a stock-and-cash deal, potentially leading to an acquisition of Humana by Cigna. The deal is seen as a move to create a company comparable in size to UnitedHealthcare and CVS/Aetna. The rumors align with Cigna's recent plan to sell its Medicare Advantage business, which experts believe could help facilitate regulatory approval for the deal. However, there may be pushback from regulators, particularly due to the fact that both companies have pharmacy benefit managers (PBMs) and are under investigation for allegedly anti-competitive practices. Despite regulatory challenges, if the deal were to go through, it could give the combined company more leverage in negotiations with providers, potentially driving down costs for customers. The article discusses how dealmaking conditions have improved in the banking industry, with executives predicting a better outlook for mergers and acquisitions. Cigna stock (CI) went down -1.95% last night, but the article does not specifically mention why.
	2023-11-30
Jim Cramer advises against a potential merger between Humana and Cigna, raising concerns about the merits of the deal and the likelihood of it passing antitrust review, which resulted in a 0.0% decrease in Cigna's stock price. Cigna's stock went down because news of a potential cash-and-stock deal with Humana was not a surprise to many industry insiders, and Cigna's management has been wanting to acquire Humana for some time. The article discusses the recent performance of Cigna Group (CI) stock, which was down 0.0% last night, and mentions that analysts at Royal Bank of Canada have reissued their "sector perform" rating on the stock with a price target of $327. The reason for the stock's decline is not specifically mentioned in the article.
	2023-11-29	-8.11 %
Cigna (CI) stock went down by 8.11% after reports emerged that the healthcare giant is in talks to merge with Humana, leading to speculation that the potential merger is the reason for Cigna exploring a sale of its Medicare Advantage business to reduce antitrust concerns. Cigna's stock (CI) went down by 8.11% last night due to investor concerns that the company could overpay for a potential merger with Humana (HUM), which is currently being discussed, and because Cigna trades at lower valuation multiples compared to Humana. Cigna (CI) stock experienced an -8.11% decrease last night, potentially due to talks of a merger with Humana, which could result in the creation of a dominant player in the health insurance industry.
	2023-11-27	-0.55 %
The article discusses Hotchkis & Wiley Capital Management LLC's increase in their position in The Cigna Group (CI) stock, as well as other hedge funds that have made changes to their positions in the company. The article does not provide a specific reason for why Cigna stock went down by -0.55%. The article discusses the importance of combating loneliness during the holiday season and highlights the disproportionate impact of loneliness on people of color. It emphasizes the need for individuals to prioritize connection and create meaningful relationships and support systems, as loneliness can negatively affect physical and mental well-being. The article suggests starting traditions or participating in activities that genuinely interest individuals as a way to foster connections and build a sense of community.
	2023-11-24	-0.16 %
The article announces that Marpai, Inc., a Third-Party Administrator (TPA) company, will host an Investors Webcast on November 29, discussing recent management changes and initiatives, which could potentially explain the decline in Cigna (CI) stock.
	2023-11-20	+0.62 %
The article discusses how weight-loss drugs, particularly GLP-1 agonists like Wegovy and Ozempic, have become a hot topic in the healthcare and consumer industry earnings calls, with companies having to respond to the potential impact on their sales. The growing popularity of these drugs, which are effective in treating diabetes and weight loss, has led to increased investor interest. The mention of these drugs in earnings transcripts for the third quarter more than doubled compared to the second quarter. The article also highlights the concerns and reactions from different companies, including major consumer products makers like Hershey and Mondelez, as well as pharmaceutical manufacturers and health insurers. The stock of companies like Eli Lilly, Novo Nordisk, and Cigna have been influenced by the discussion around these drugs. The potential long-term use and impact of these drugs are still being explored. The article discusses the impact of weight-loss medications on healthcare and consumer companies, with Cigna (CI) stock experiencing a 0.62% increase. The growing popularity of GLP-1 agonists, such as Eli Lilly's Zepbound and Novo Nordisk's Wegovy, which have proven effective in treating diabetes and weight loss, may be a contributing factor to the stock's rise. However, the long-term impact of these medications and their pricing are still uncertain. Cigna (CI) stock went up 0.62% as there is growing investor interest in GLP-1 agonists, a class of drugs used for weight loss and treating diabetes, and analysts have been questioning healthcare companies about their potential impact on sales.
	2023-11-17	+0.11 %
The article discusses Boston Scientific Corporation's acquisition of Relievant Medsystems Inc., which offers the Intracept Intraosseous Nerve Ablation System for treating vertebrogenic pain. The acquisition expands access to the Intracept system through healthcare plan coverage from Anthem Blue Cross Blue Shield, Humana, and Cigna Healthcare, which contributed to the increase in Cigna's stock.
	2023-11-16	-0.26 %
In its most recent filing with the SEC, TD Asset Management Inc revealed that it reduced its holdings in Cigna Group by 4.5% during the 2nd quarter, which may explain why the stock went down; however, the article does not provide any specific reason for the decline. The article discusses that Cigna Group (CI) stock went down by 0.26%, and it mentions that Checchi Capital Advisers LLC decreased its holdings in the company's stock, possibly contributing to the decrease. However, there is no concrete explanation given for why the stock went down.
	2023-11-15	-2.45 %
Cigna (CI) stock went down by 2.45% last night; however, the article does not mention the reason for the decline. The article mentions that shares of Cigna Group (CI) fell 2.45% and the stock underperformed its competitors, but does not provide a specific reason for the decline in the stock price. The article reports that hedge funds and institutional investors have been buying and selling shares of The Cigna Group (CI). The stock of Cigna Group went down by 2.45% on the previous night. The reason for the decline is not specifically mentioned in the article.
	2023-11-14	-1.37 %
The article discusses Michael Burry's bearish bets revealed in a quarterly filing from his Scion Asset Management, including a bet against an index of semiconductor stocks and the company formerly known as Priceline.com. The article does not specifically mention why Cigna (CI) stock went down. The Cigna Group (CI) stock went down by -1.37% last night, and the reason for the decline is not mentioned in the article.
	2023-11-13	+0.31 %
The article discusses how Cim Investment Management Inc. increased its position in The Cigna Group stock during the second quarter, which may have contributed to the stock's upward movement.
	2023-11-10	+1.49 %
The article discusses the increase in Cigna's stock (CI) by 1.49% and does not provide any information or analysis regarding the reason behind the stock's increase. The article discusses how Commerce Bank increased its holdings in The Cigna Group by 1.3% in the second quarter, which may have contributed to the stock's recent increase. Additionally, other institutional investors have made changes to their positions in the company, and several brokerages have issued positive reports on the stock. The Cigna Group recently reported strong quarterly earnings and declared a dividend, further contributing to investor confidence in the stock.
	2023-11-08	+0.11 %
The article announces the appointment of Charles A. Brawley, III as Executive Vice President, General Counsel and Corporate Secretary of Campbell Soup Company, which may have had a positive impact on Cigna (CI) stock as Brawley previously worked at Cigna Corporation.
	2023-11-07	-3.85 %
The article discusses the third-quarter financial results of Oscar Health, a healthcare technology company. It mentions that the company's InsuranceCo Adjusted EBITDA and consolidated Adjusted EBITDA have outperformed expectations, leading to a positive outlook for the rest of the year. The article does not provide any information specific to Cigna (CI) stock or why it may have gone down.
	2023-11-06	-1.23 %
Cigna is considering selling its Medicare Advantage business, which could fetch billions of dollars, due to tightening government reimbursement and lower profit margins in the sector. The exact reason for Cigna's stock going down is not specified in the article. Cigna (CI) stock went down because Mark Cuban's online pharmacy, Mark Cuban Cost Plus Drug Co., is disrupting the pharmaceutical supply chain by offering medications at significantly lower prices, causing concern among investors and industry analysts about the future of companies currently dominating the industry. The article discusses the performance of Cigna (CI) stock, which recently experienced a decrease of -1.23%, and explains that the reason for the decline is not mentioned in the article.
	2023-11-03	-2.58 %
The article discusses the recent performance of Colgate-Palmolive (CL) stock and its financial results, with a boost in stake by Savant Capital LLC, and provides information on other institutional investors' holdings in the company. The article does not explain why Cigna (CI) stock went down.
	2023-11-02	+3.06 %
The article reports that Cigna (CI) stock went up 3.06% last night, likely due to the company's strong third-quarter results, which reflect revenue and earnings growth across its various businesses. The Cigna Group (CI) stock went up by 3.06% because American International Group Inc. reduced its stake in the company in the second quarter, and other hedge funds and institutional investors also added to or reduced their stakes. The article discusses the increase in Cigna Group's stock (CI) by 3.06% on the previous night. The reason behind the increase is not specifically mentioned in the article.
	2023-11-01	+0.07 %
The article reports that Cigna Group's stock (CI) increased by 0.07% recently, but it does not provide a specific reason for the stock's rise. The article discusses a decrease in ownership stake in The Cigna Group (CI) by EverSource Wealth Advisors LLC and various other hedge funds, as well as recent insider selling of CI stock. The stock price of CI went up by 0.07% last night. The reason for the increase in CI stock price is not mentioned in the article. Cigna (CI) stock went up by 0.07% last night because Quantinno Capital Management LP increased its stake in the company, along with other hedge funds and institutional investors making changes to their positions, leading to a positive outlook for the stock.
	2023-10-30	+0.65 %
The article discusses three major trends that have defined digital health in 2023 and the challenges they have created. These trends include the integration of in-person care, telehealth, and virtual care; the need for effective evaluation of digital health programs; and the management of multiple point solutions for chronic conditions. The article also mentions the overwhelming demand for weight loss drugs and the importance of comprehensive behavioral support. The overall trend in digital health funding is declining, but the strongest and most innovative companies will survive and shape the future of care.
	2023-10-27	-0.32 %
The article discusses how BI Asset Management Fondsmaeglerselskab A S increased its holdings in Cigna Group's stock by 30.8% during the second quarter, but does not provide a specific reason for the recent decline in the stock price. Cigna Group's stock (CI) went down by 0.32% due to an overall poor trading session for the stock market, with the S&P 500 Index and Dow Jones Industrial Average also falling.
	2023-10-26	+0.11 %
The Cigna Group (NYSE: CI) stock went up possibly because of the positive findings from their second annual Vitality in America report, which showed that despite challenges in personal health, finances, and job satisfaction, Americans are feeling more optimistic than last year, with nearly half of adults looking forward to each day.
	2023-10-25	-0.25 %
The article discusses Cigna Group's declaration of a cash dividend of $1.23 per share of its common stock and provides information about the company. The reason for Cigna's stock decline is not mentioned in the article.
	2023-10-24	+1.19 %
The article is about Walgreens and the fact that its stock has jumped after J.P. Morgan expressed confidence in new CEO Tim Wentworth's ability to improve the company's performance by reducing overhangs. The article does not provide information about why Cigna (CI) stock went up. The article reports that Chubb Limited (NYSE: CB) saw its net income and core operating income increase in the third quarter of 2023, with the company's stock experiencing a 1.19% increase. The stock went up due to Chubb's increased ownership in Huatai Group (Huatai) and the application of consolidation accounting, which positively impacted Chubb's financial position. The Cigna Group (CI) stock went up by 1.19% after the company announced that Brian Evanko, executive vice president and chief financial officer, will present at the 5th Annual Wolfe Research Healthcare Conference on November 14, 2023 in New York, NY.

1
500 / page